HSPB8 and type 2 diabetes mellitus: These data together indicated that HSP22 attenuated vascular lesions in a T2DM (type 2 diabetes mellitus) mouse model, which may be beneficial for the inhibition of pathogenesis of diabetic heart diseases by suppressing mtROS-mediated endothelial activation [24].